semaglutide 2.0 mg approval FDA Clears For Cardiac Risk Reduction in Diabetic Patients Ozempic Semaglutide 2mg Injection Prefilled

A longitudinal study found that 25% of MINOCA patients had non-ischemic cardiomyopathy, which was associated with the highest mortality compared to other MINOCA mechanisms

Based on these convergent findings, we conclude that GABAergic inhibition in the PVN, driven by activation of OB Glp1r -expressing neurons, decreased sympathetic nerve activity to the pancreas, thereby increasing insulin release in WD mice

At the same time, stopping semaglutide doesnt guarantee reversal

GLP-1 targeting drugs act as GLP-1 receptor agonists or inhibitors of the GLP-1 degrading enzyme, dipeptidylpeptidase IV (11)

Lost 34 lbs total

Educational reference only not a dose recommendation